Drugs / LV
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT07585279 Background | May 2026 → Feb 2031 expected | colorectal cancer | Hebei Medical University Fourth Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07585279 ↗ |
| Route | Intravenous | “LV: 400mg/m², intravenous infusion within 30 minutes” NCT07585279 ↗ |